Press release
Neurological Biomarkers Market Foreseen to Grow Exponentially Over 2018-2025
Neurological Biomarkers Market
The major companies profiled in this report include Abbott Laboratories, Myriad RBM, Proteome Sciences, Thermo Fisher Scientific, Athena Diagnostics, Immunarray Pvt. Ltd.,
Quanterix Corporation, Diagenic ASA, Psynova Neurotech, and Bio-Rad Laboratories. Other prominent players in the value chain include Qiagen, AbaStar MDx, Acumen Pharmaceuticals, Abiant, Alseres Pharmaceuticals, Athena Diagnostics, Banyan Biomarkers, and ProteoSys AG.
Increase in demand for noninvasive neurological biomarkers is expected to supplement the market growth. Furthermore, rise in number of research activities focused towards developing efficient biomarkers that can aid in early diagnosis of Alzheimer‐™s and Parkinson‐™s diseases is expected to drive the market growth in the near future. For instance, MSDx, Inc. is developing cost-effective and reliable blood-based neurological biomarkers that can aid in detecting the onset of disease before excessive damage occurs. The company has patented the blood test and has named it as the ‐Window into The Brain
Download Sample PDF Brochure of Neurological Biomarkers Market at: https://www.alliedmarketresearch.com/request-sample/3555
The neurological biomarkers market for Alzheimers disease generated a revenue of $2,636.7 million in 2017, and is expected to reach $6,122.5 million by 2025, registering a CAGR of 11.1% from 2018 to 2025. Conversely, neurological biomarkers market for Parkinsons disease generated a revenue of $1,321.8 million in 2017, and is expected to reach $2,457.4 million by 2025 registering a CAGR of 8.0%.
Upsurge in the incidence of Alzheimers and Parkinsons diseases is anticipated to contribute to the robust growth of neurological biomarkers. In addition, increase in adoption of neurological biomarkers in drug development and validation has been witnessed over the years to improve the accuracy of clinical trials. Furthermore, rise in preference towards personalized medicine is expected to offer profitable opportunities for the expansion of neurological biomarkers applied across Alzheimers and Parkinsons.
Based on the region, the neurological biomarkers market for Alzheimers and Parkinsons diseases is studied across the U.S., EU5, rest of Europe, China, Asia-Pacific, and rest of the world (ROW). The U.S. dominated the market for Alzheimers and Parkinsons in 2017, and is expected to continue this trend throughout the forecast period. In addition, Asia-Pacific is anticipated to grow at the fastest pace in Alzheimers neurological biomarkers market during the forecast period, whereas China is expected to register highest growth rate from 2018 to 2025 in the Parkinsons neurological biomarkers market.
Buy Now at: https://www.alliedmarketresearch.com/checkout/574473
About us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David C
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neurological Biomarkers Market Foreseen to Grow Exponentially Over 2018-2025 here
News-ID: 1661463 • Views: …
More Releases from Allied Market Research
3D Animation Market Expanding at a Healthy 14.2% CAGR, To Reach a Value of $72.8 …
The 3d animation industry was valued at $19.5 billion in 2022, and is estimated to reach $72.8 billion by 2032, growing at a CAGR of 14.2% from 2023 to 2032.
The idea of characters, logos, images, and other movie elements morphing is becoming more popular. It is a switchover effect that is used to smoothly change one image or shape into another in movies and animations. It draws the audience's attention…
Dry Natural Gas Market Is Set to Garner Staggering Revenues By 2031
Increased innovation in natural gas drying equipment is a key market trend that offers opportunities for prominent players in the forecast period. Dry natural gas is preferable for environmental and public health. The use of natural gas as energy resource in power generation systems is anticipated to drive power generation system. The increased environmental concerns, increased government initiatives for the construction of dry gas processing infrastructure, expensive initial infrastructure investment,…
Robotics Market is Growing At A CAGR of 27.7% from 2021 to 2030 | Latest Researc …
According to a new report published by Allied Market Research, titled,the global robotics market size was valued at $12.1 billion in 2020, and is expected to reach $149.9 billion by 2030, with a CAGR of 27.7% from 2021 to 2030.
In 2020, Europe dominated the global robotics market, in terms of revenue, accounting for around 44.4% share of the global market. The scope of the market limits to the study…
Clean Hydrogen Market to Witness Comprehensive Growth by 2032
Clean hydrogen is the form of hydrogen that is produced through processes that result in lower carbon emissions (through carbon capture, storage, and utilization (CCUS)) or zero carbon emissions. Climate change and net-zero commitments are major reasons for the shift from fossil fuels to alternatives such as synthetic fuels, renewables, nuclear fusion energy, clean hydrogen, and others. Several advanced hydrogen technologies are being developed and countries are positioning themselves to…
More Releases for Alzheimers
Alzheimers Disease Treatment Market Size, Report 2022-2030
Acumen Research and Consulting has announced the addition of the "Alzheimer's Disease Treatment Market" report to their offering.
The Alzheimer's Disease Treatment Market Report 2030 is an in depth study analyzing the current state of the Alzheimer's Disease Treatment Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Alzheimer's Disease Treatment Market provides analysis of global market covering…
Rugged Expansion Foreseen by Alzheimers Disease Market
ResearchMoz include new market research report "Frontier Pharma: Alzheimers Disease and Associated Indications - Exceptional Level of First-in-Class Innovation within AD, and Diverse Range of Therapies in Development for Disorders Such as Anxiety and Depression" to its huge collection of research reports.
Alzheimer’s disease (AD), the most common form of dementia, is a progressive, neurodegenerative and currently incurable disease characterized by loss of memory and other mental abilities. It has a…
Alzheimers Disease Therapeutics Market - Technological Advancements Enhancing th …
Alzheimer’s disease is a neurodegenerative, progressive, non-reversible disorder. Alzheimer’s disease is caused due to abnormal functioning of brain cells i.e. failure of synaptic transmission, resulting in the loss of cognitive functions. Some of the signs and symptoms of alzheimer’s disease are memory loss, insomnia, repetitive movements, agitation, anxiety, depression and loss of reasoning abilities. All memory and mental functioning may be lost in advanced stages of the disease. Alzheimer’s disease…
Alzheimers Drug Market Size, Share and Forecast till 2022
Alzheimers Drug Report by Material, Application, and Geography - Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).
Request Sample Copy of the Business Report @ https://www.worldwidemarketreports.com/sample/26138
The report firstly introduced the Alzheimers Drug basics: definitions, classifications, applications and…
Global Alzheimers Disease Drug Market Professional Survey Report 2017
This report studies Alzheimers Disease Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck.
Get free PDF brochure of the report at: https://www.qyresearchreports.com/sample/sample.php?rep_id=1339210&type=E
On the…
Alzheimers Disease - Heat Map and Analysis
Albany, NY, Feb 27, 2017: Alzheimers disease (AD) is an irreversible, progressive neurodegenerative disease, characterized by cognitive impairment, memory loss and functional decline. The pathological features of AD comprise a complex set of histopathological changes within the brain. Symptoms typically begin to first appear in patients in their mid-sixties, and appear in varying stages. The effects of AD, particularly at an advanced stage, are devastating to patients and their caregivers,…
